Company
Maze Therapeutics, Inc. (MAZE)
Standardized SEC financial data for Maze Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001842295 · NASDAQ · Biological Products, (No Diagnostic Substances).
Income statement
| USD | FY2024 | FY2025 |
|---|---|---|
| Revenue | $167.5M | — |
| R&D expense | $83.5M | $108.4M |
| SG&A expense | $26.4M | $34.5M |
| Operating income | $57.6M | -$142.9M |
| Pretax income | $53.4M | -$131.1M |
| Income tax | $1.2M | $0 |
| Net income | $52.2M | -$131.1M |
| EPS (diluted) | $1.25 | $-3.05 |
Standardized from Maze Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $30.2M | $197.9M | $190.3M |
| Total current assets | — | $201.7M | $349.7M |
| Property, plant & equipment | — |
Get MAZE data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MAZE/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MAZE/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"